_id
6911b7b2ccc777a4e85d60a4
Ticker
FTRE
Name
Fortrea Holdings Inc.
Exchange
NASDAQ
Address
8 Moore Drive, Durham, NC, United States, 27709
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.fortrea.com
Description
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. The company has a strategic collaboration with SCT Cell Manufacturing s.r.o. to streamline development, accelerate timelines and bring advanced therapies to patients faster. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Last Close
17.26
Volume
1175293
Current Price
17.72
Change
-0.44
Last Updated
2026-01-03T12:12:44.055Z
Image
-
Ipo Date
2023-07-03T00:00:00.000Z
Market Cap
1553243904
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.9965
Sentiment Sources
6
Rating
3
Target Price
13.2546
Strong Buy
0
Buy
1
Hold
10
Sell
1
Strong Sell
0
Current Quarter
2025-09-30
Revenue
701300000
Cost Of Revenue
598200000
Gross Profit
103100000
Operating Expenses
119000000
Operating Income
-15900000
Interest Expense
22600000
Pretax Income
-28700000
Net Income
-15900000
Eps
-0.17434210526315788
Dividends Per Share
-
Shares Outstanding
92400000
Income Tax Expense
-12800000
EBITDA
13500000
Operating Margin
-2.2672180236703263
Total Other Income Expense Net
-12800000
Cash
131300000
Short Term Investments
-
Receivables
663200000
Inventories
-
Total Current Assets
918500000
Property Plant Equipment
147600000
Total Assets
2742100000
Payables
49500000
Short Term Debt
83700000
Long Term Debt
1052100000
Total Liabilities
2161300000
Equity
580800000
Bs_currency_symbol
USD
Depreciation
19600000
Change In Working Capital
60200000
Cash From Operations
86800000
Capital Expenditures
7300000
Cash From Investing
13300000
Cash From Financing
-50000000
Net Change In Cash
50100000
Cf_currency_symbol
USD
PE
-
PB
2.782479338842975
ROE
-2.737603305785124
ROA
-0.5798475620874513
FCF
79500000
Fcf Percent
0.11336090118351633
Piotroski FScore
2
Health Score
27
Deep Value Investing Score
3.5
Defensive Investing Score
5.5
Dividend Investing Score
3
Economic Moat Investing Score
4.8
Garp Investing Score
2.5
Growth Investing Score
2.5
Momentum Investing Score
2.5
Net Net Investing Score
2.5
Quality Investing Score
3
Value Investing Score
3
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
701300000
Quarters > 0 > income Statement > cost Of Revenue
598200000
Quarters > 0 > income Statement > gross Profit
103100000
Quarters > 0 > income Statement > operating Expenses
119000000
Quarters > 0 > income Statement > operating Income
-15900000
Quarters > 0 > income Statement > interest Expense
22600000
Quarters > 0 > income Statement > pretax Income
-28700000
Quarters > 0 > income Statement > net Income
-15900000
Quarters > 0 > income Statement > eps
-0.17434210526315788
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
91200000
Quarters > 0 > income Statement > income Tax Expense
-12800000
Quarters > 0 > income Statement > EBITDA
13500000
Quarters > 0 > income Statement > operating Margin
-2.2672180236703263
Quarters > 0 > income Statement > total Other Income Expense Net
-12800000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
131300000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
663200000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
918500000
Quarters > 0 > balance Sheet > property Plant Equipment
147600000
Quarters > 0 > balance Sheet > total Assets
2742100000
Quarters > 0 > balance Sheet > payables
49500000
Quarters > 0 > balance Sheet > short Term Debt
83700000
Quarters > 0 > balance Sheet > long Term Debt
1052100000
Quarters > 0 > balance Sheet > total Liabilities
2161300000
Quarters > 0 > balance Sheet > equity
580800000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-15900000
Quarters > 0 > cash Flow > depreciation
19600000
Quarters > 0 > cash Flow > change In Working Capital
60200000
Quarters > 0 > cash Flow > cash From Operations
86800000
Quarters > 0 > cash Flow > capital Expenditures
7300000
Quarters > 0 > cash Flow > cash From Investing
13300000
Quarters > 0 > cash Flow > cash From Financing
-50000000
Quarters > 0 > cash Flow > net Change In Cash
50100000
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.17434210526315788
Quarters > 0 > ratios > PB
2.782479338842975
Quarters > 0 > ratios > ROE
-2.737603305785124
Quarters > 0 > ratios > ROA
-0.5798475620874513
Quarters > 0 > ratios > FCF
79500000
Quarters > 0 > ratios > Piotroski FScore
2
Quarters > 0 > ratios > fcf Percent
0.11336090118351633
Quarters > 0 > health Score
27
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
710300000
Quarters > 1 > income Statement > cost Of Revenue
596400000
Quarters > 1 > income Statement > gross Profit
113900000
Quarters > 1 > income Statement > operating Expenses
124800000
Quarters > 1 > income Statement > operating Income
-10900000
Quarters > 1 > income Statement > interest Expense
23200000
Quarters > 1 > income Statement > pretax Income
-370700000
Quarters > 1 > income Statement > net Income
-374900000
Quarters > 1 > income Statement > eps
-4.137969094922737
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
90600000
Quarters > 1 > income Statement > income Tax Expense
4200000
Quarters > 1 > income Statement > EBITDA
-327900000
Quarters > 1 > income Statement > operating Margin
-1.5345628607630577
Quarters > 1 > income Statement > total Other Income Expense Net
-359800000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
81200000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
739200000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
960000000
Quarters > 1 > balance Sheet > property Plant Equipment
148700000
Quarters > 1 > balance Sheet > total Assets
2835100000
Quarters > 1 > balance Sheet > payables
92600000
Quarters > 1 > balance Sheet > short Term Debt
87200000
Quarters > 1 > balance Sheet > long Term Debt
1100900000
Quarters > 1 > balance Sheet > total Liabilities
2245900000
Quarters > 1 > balance Sheet > equity
589200000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-374900000
Quarters > 1 > cash Flow > depreciation
19600000
Quarters > 1 > cash Flow > change In Working Capital
10300000
Quarters > 1 > cash Flow > cash From Operations
21800000
Quarters > 1 > cash Flow > capital Expenditures
7500000
Quarters > 1 > cash Flow > cash From Investing
-7500000
Quarters > 1 > cash Flow > cash From Financing
-39000000
Quarters > 1 > cash Flow > net Change In Cash
-20400000
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-4.137969094922737
Quarters > 1 > ratios > PB
2.724765784114053
Quarters > 1 > ratios > ROE
-63.62864901561439
Quarters > 1 > ratios > ROA
-13.22351945257663
Quarters > 1 > ratios > FCF
14300000
Quarters > 1 > ratios > Piotroski FScore
2
Quarters > 1 > ratios > fcf Percent
0.02013233844854287
Quarters > 1 > health Score
18
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
651300000
Quarters > 2 > income Statement > cost Of Revenue
534800000
Quarters > 2 > income Statement > gross Profit
116500000
Quarters > 2 > income Statement > operating Expenses
636600000
Quarters > 2 > income Statement > operating Income
-520100000
Quarters > 2 > income Statement > interest Expense
22300000
Quarters > 2 > income Statement > pretax Income
-548000000
Quarters > 2 > income Statement > net Income
-562900000
Quarters > 2 > income Statement > eps
-6.296420581655481
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
89400000
Quarters > 2 > income Statement > income Tax Expense
14900000
Quarters > 2 > income Statement > EBITDA
-506200000
Quarters > 2 > income Statement > operating Margin
-79.85567326884691
Quarters > 2 > income Statement > total Other Income Expense Net
-27900000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
101600000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
729000000
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
970300000
Quarters > 2 > balance Sheet > property Plant Equipment
150200000
Quarters > 2 > balance Sheet > total Assets
3121100000
Quarters > 2 > balance Sheet > payables
110200000
Quarters > 2 > balance Sheet > short Term Debt
177300000
Quarters > 2 > balance Sheet > long Term Debt
1049900000
Quarters > 2 > balance Sheet > total Liabilities
2262300000
Quarters > 2 > balance Sheet > equity
858800000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-562900000
Quarters > 2 > cash Flow > depreciation
19500000
Quarters > 2 > cash Flow > change In Working Capital
-88600000
Quarters > 2 > cash Flow > cash From Operations
-124200000
Quarters > 2 > cash Flow > capital Expenditures
2900000
Quarters > 2 > cash Flow > cash From Investing
16100000
Quarters > 2 > cash Flow > cash From Financing
88400000
Quarters > 2 > cash Flow > net Change In Cash
-16900000
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-6.296420581655481
Quarters > 2 > ratios > PB
1.844629715882627
Quarters > 2 > ratios > ROE
-65.54494643688868
Quarters > 2 > ratios > ROA
-18.035308064464452
Quarters > 2 > ratios > FCF
-127100000
Quarters > 2 > ratios > Piotroski FScore
1
Quarters > 2 > ratios > fcf Percent
-0.19514816520804545
Quarters > 2 > health Score
21
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
697000000
Quarters > 3 > income Statement > cost Of Revenue
556100000
Quarters > 3 > income Statement > gross Profit
140900000
Quarters > 3 > income Statement > operating Expenses
196500000
Quarters > 3 > income Statement > operating Income
-55600000
Quarters > 3 > income Statement > interest Expense
21900000
Quarters > 3 > income Statement > pretax Income
-74900000
Quarters > 3 > income Statement > net Income
-61200000
Quarters > 3 > income Statement > eps
-0.68
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
90000000
Quarters > 3 > income Statement > income Tax Expense
-1000000
Quarters > 3 > income Statement > EBITDA
-32200000
Quarters > 3 > income Statement > operating Margin
-7.977044476327117
Quarters > 3 > income Statement > total Other Income Expense Net
-19300000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
118500000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
694000000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
948200000
Quarters > 3 > balance Sheet > property Plant Equipment
156300000
Quarters > 3 > balance Sheet > total Assets
3579200000
Quarters > 3 > balance Sheet > payables
138200000
Quarters > 3 > balance Sheet > short Term Debt
88200000
Quarters > 3 > balance Sheet > long Term Debt
1049700000
Quarters > 3 > balance Sheet > total Liabilities
2216800000
Quarters > 3 > balance Sheet > equity
1362400000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-73900000
Quarters > 3 > cash Flow > depreciation
20800000
Quarters > 3 > cash Flow > change In Working Capital
34200000
Quarters > 3 > cash Flow > cash From Operations
17100000
Quarters > 3 > cash Flow > capital Expenditures
3200000
Quarters > 3 > cash Flow > cash From Investing
3500000
Quarters > 3 > cash Flow > cash From Financing
-1100000
Quarters > 3 > cash Flow > net Change In Cash
13200000
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.68
Quarters > 3 > ratios > PB
1.1705813270698766
Quarters > 3 > ratios > ROE
-4.4920728126834994
Quarters > 3 > ratios > ROA
-1.7098793026374608
Quarters > 3 > ratios > FCF
13900000
Quarters > 3 > ratios > Piotroski FScore
2
Quarters > 3 > ratios > fcf Percent
0.01994261119081779
Quarters > 3 > health Score
26
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
2696400000
Annuals > 0 > income Statement > cost Of Revenue
2162200000
Annuals > 0 > income Statement > gross Profit
534200000
Annuals > 0 > income Statement > operating Expenses
696100000
Annuals > 0 > income Statement > operating Income
-161900000
Annuals > 0 > income Statement > interest Expense
123800000
Annuals > 0 > income Statement > pretax Income
-275000000
Annuals > 0 > income Statement > net Income
-328500000
Annuals > 0 > income Statement > eps
-3.670391061452514
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
89500000
Annuals > 0 > income Statement > income Tax Expense
-3500000
Annuals > 0 > income Statement > EBITDA
-64300000
Annuals > 0 > income Statement > operating Margin
-6.004302032339416
Annuals > 0 > income Statement > total Other Income Expense Net
-113100000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
118500000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
694000000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
948200000
Annuals > 0 > balance Sheet > property Plant Equipment
156300000
Annuals > 0 > balance Sheet > total Assets
3579200000
Annuals > 0 > balance Sheet > payables
138200000
Annuals > 0 > balance Sheet > short Term Debt
88200000
Annuals > 0 > balance Sheet > long Term Debt
1049700000
Annuals > 0 > balance Sheet > total Liabilities
2216800000
Annuals > 0 > balance Sheet > equity
1362400000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-271500000
Annuals > 0 > cash Flow > depreciation
98000000
Annuals > 0 > cash Flow > change In Working Capital
364500000
Annuals > 0 > cash Flow > cash From Operations
262800000
Annuals > 0 > cash Flow > capital Expenditures
25500000
Annuals > 0 > cash Flow > cash From Investing
251600000
Annuals > 0 > cash Flow > cash From Financing
-497800000
Annuals > 0 > cash Flow > net Change In Cash
9900000
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.670391061452514
Annuals > 0 > ratios > PB
1.104297563123899
Annuals > 0 > ratios > ROE
-24.111861421021725
Annuals > 0 > ratios > ROA
-9.178028609745194
Annuals > 0 > ratios > FCF
237300000
Annuals > 0 > ratios > Piotroski FScore
2
Annuals > 0 > ratios > fcf Percent
0.08800623052959501
Annuals > 0 > health Score
33
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
2842500000
Annuals > 1 > income Statement > cost Of Revenue
2251900000
Annuals > 1 > income Statement > gross Profit
590600000
Annuals > 1 > income Statement > operating Expenses
558600000
Annuals > 1 > income Statement > operating Income
32000000
Annuals > 1 > income Statement > interest Expense
69800000
Annuals > 1 > income Statement > pretax Income
-30500000
Annuals > 1 > income Statement > net Income
-25200000
Annuals > 1 > income Statement > eps
-0.28378378378378377
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
88800000
Annuals > 1 > income Statement > income Tax Expense
1200000
Annuals > 1 > income Statement > EBITDA
137200000
Annuals > 1 > income Statement > operating Margin
1.125769569041337
Annuals > 1 > income Statement > total Other Income Expense Net
-62500000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
108600000
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1010500000
Annuals > 1 > balance Sheet > inventories
35300000
Annuals > 1 > balance Sheet > total Current Assets
1250800000
Annuals > 1 > balance Sheet > property Plant Equipment
172600000
Annuals > 1 > balance Sheet > total Assets
4332600000
Annuals > 1 > balance Sheet > payables
132900000
Annuals > 1 > balance Sheet > short Term Debt
43300000
Annuals > 1 > balance Sheet > long Term Debt
1565900000
Annuals > 1 > balance Sheet > total Liabilities
2618500000
Annuals > 1 > balance Sheet > equity
1714100000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-25200000
Annuals > 1 > cash Flow > depreciation
98000000
Annuals > 1 > cash Flow > change In Working Capital
26900000
Annuals > 1 > cash Flow > cash From Operations
168400000
Annuals > 1 > cash Flow > capital Expenditures
40300000
Annuals > 1 > cash Flow > cash From Investing
-31800000
Annuals > 1 > cash Flow > cash From Financing
-140800000
Annuals > 1 > cash Flow > net Change In Cash
-1800000
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-0.28378378378378377
Annuals > 1 > ratios > PB
0.8708523423370864
Annuals > 1 > ratios > ROE
-1.4701592672539525
Annuals > 1 > ratios > ROA
-0.5816368923971749
Annuals > 1 > ratios > FCF
128100000
Annuals > 1 > ratios > Piotroski FScore
2
Annuals > 1 > ratios > fcf Percent
0.04506596306068602
Annuals > 1 > health Score
27
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
2837000000
Annuals > 2 > income Statement > cost Of Revenue
2112600000
Annuals > 2 > income Statement > gross Profit
724400000
Annuals > 2 > income Statement > operating Expenses
537300000
Annuals > 2 > income Statement > operating Income
187100000
Annuals > 2 > income Statement > interest Expense
200000
Annuals > 2 > income Statement > pretax Income
187000000
Annuals > 2 > income Statement > net Income
186200000
Annuals > 2 > income Statement > eps
2.1063348416289593
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
88400000
Annuals > 2 > income Statement > income Tax Expense
41100000
Annuals > 2 > income Statement > EBITDA
280800000
Annuals > 2 > income Statement > operating Margin
6.594994712724709
Annuals > 2 > income Statement > total Other Income Expense Net
-100000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
112000000
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1051400000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
1246900000
Annuals > 2 > balance Sheet > property Plant Equipment
164900000
Annuals > 2 > balance Sheet > total Assets
4287900000
Annuals > 2 > balance Sheet > payables
81500000
Annuals > 2 > balance Sheet > short Term Debt
23300000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
945300000
Annuals > 2 > balance Sheet > equity
3342600000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
186200000
Annuals > 2 > cash Flow > depreciation
93600000
Annuals > 2 > cash Flow > change In Working Capital
-248200000
Annuals > 2 > cash Flow > cash From Operations
82700000
Annuals > 2 > cash Flow > capital Expenditures
54400000
Annuals > 2 > cash Flow > cash From Investing
-54000000
Annuals > 2 > cash Flow > cash From Financing
-6300000
Annuals > 2 > cash Flow > net Change In Cash
15800000
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
2.1063348416289593
Annuals > 2 > ratios > PB
0.4445653084425297
Annuals > 2 > ratios > ROE
5.570513971160175
Annuals > 2 > ratios > ROA
4.342452016138436
Annuals > 2 > ratios > FCF
28300000
Annuals > 2 > ratios > Piotroski FScore
4
Annuals > 2 > ratios > fcf Percent
0.009975326048642933
Annuals > 2 > health Score
58
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
3057500000
Annuals > 3 > income Statement > cost Of Revenue
2453100000
Annuals > 3 > income Statement > gross Profit
604400000
Annuals > 3 > income Statement > operating Expenses
490100000
Annuals > 3 > income Statement > operating Income
114300000
Annuals > 3 > income Statement > interest Expense
200000
Annuals > 3 > income Statement > pretax Income
136400000
Annuals > 3 > income Statement > net Income
98000000
Annuals > 3 > income Statement > eps
1.1085972850678734
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
88400000
Annuals > 3 > income Statement > income Tax Expense
38400000
Annuals > 3 > income Statement > EBITDA
302900000
Annuals > 3 > income Statement > operating Margin
3.7383483237939488
Annuals > 3 > income Statement > total Other Income Expense Net
22100000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
94600000
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
949800000
Annuals > 3 > balance Sheet > inventories
-
Annuals > 3 > balance Sheet > total Current Assets
1117500000
Annuals > 3 > balance Sheet > property Plant Equipment
162600000
Annuals > 3 > balance Sheet > total Assets
4368700000
Annuals > 3 > balance Sheet > payables
60500000
Annuals > 3 > balance Sheet > short Term Debt
24000000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
1108100000
Annuals > 3 > balance Sheet > equity
3260600000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
98000000
Annuals > 3 > cash Flow > depreciation
166300000
Annuals > 3 > cash Flow > change In Working Capital
-127200000
Annuals > 3 > cash Flow > cash From Operations
169800000
Annuals > 3 > cash Flow > capital Expenditures
26500000
Annuals > 3 > cash Flow > cash From Investing
-26200000
Annuals > 3 > cash Flow > cash From Financing
-128500000
Annuals > 3 > cash Flow > net Change In Cash
14300000
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
1.1085972850678734
Annuals > 3 > ratios > PB
0.45574556830031276
Annuals > 3 > ratios > ROE
3.0055817947617003
Annuals > 3 > ratios > ROA
2.2432302515622498
Annuals > 3 > ratios > FCF
143300000
Annuals > 3 > ratios > Piotroski FScore
3
Annuals > 3 > ratios > fcf Percent
0.04686835650040883
Annuals > 3 > health Score
57
Valuation > metrics > PE
-0.17434210526315788
Valuation > metrics > PB
2.782479338842975
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-2.737603305785124
Profitability > metrics > ROA
-1.7310832879695155
Profitability > metrics > Net Margin
-0.022672180236703265
Profitability > final Score
0
Profitability > verdict
Weak
Risk > metrics > Debt Equity
3.721246556473829
Risk > metrics > Interest Coverage
-0.7035398230088495
Risk > final Score
3
Risk > verdict
High
Liquidity > metrics > Current Ratio
6.895645645645645
Liquidity > metrics > Quick Ratio
6.895645645645645
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
0
Prev Profitabilities > 1
0
Prev Profitabilities > 2
0
Prev Risks > 0
4
Prev Risks > 1
-75
Prev Risks > 2
20
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:52:20.000Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-05
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0.12
Earnings History > 0 > eps Estimate
0.48
Earnings History > 0 > eps Difference
-0.36
Earnings History > 0 > surprise Percent
-75
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-06
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-4.14
Earnings History > 1 > eps Estimate
0.08
Earnings History > 1 > eps Difference
-4.22
Earnings History > 1 > surprise Percent
-5275
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-12
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
0.02
Earnings History > 2 > eps Estimate
-0.0573
Earnings History > 2 > eps Difference
0.0773
Earnings History > 2 > surprise Percent
134.904
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-10
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
0.18
Earnings History > 3 > eps Estimate
0.3653
Earnings History > 3 > eps Difference
-0.1853
Earnings History > 3 > surprise Percent
-50.7254
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-11
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
0.23
Earnings History > 4 > eps Estimate
0.25
Earnings History > 4 > eps Difference
-0.02
Earnings History > 4 > surprise Percent
-8
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-12
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.03
Earnings History > 5 > eps Estimate
0.08
Earnings History > 5 > eps Difference
-0.11
Earnings History > 5 > surprise Percent
-137.5
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-13
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.04
Earnings History > 6 > eps Estimate
0.01
Earnings History > 6 > eps Difference
-0.05
Earnings History > 6 > surprise Percent
-500
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-11
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
0.19
Earnings History > 7 > eps Estimate
0.24
Earnings History > 7 > eps Difference
-0.05
Earnings History > 7 > surprise Percent
-20.8333
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-13
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.15
Earnings History > 8 > eps Estimate
0.16
Earnings History > 8 > eps Difference
-0.31
Earnings History > 8 > surprise Percent
-193.75
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-24
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
AfterMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.52
Earnings History > 9 > eps Estimate
-
Earnings History > 9 > eps Difference
0
Earnings History > 9 > surprise Percent
-
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-31
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
-
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
0.454
Earnings History > 10 > eps Estimate
0
Earnings History > 10 > eps Difference
0.454
Earnings History > 10 > surprise Percent
-
Fortrea Holdings Inc., a contract research organization, provides biopharmaceutical product and medical device development solutions to pharmaceutical, biotechnology, and medical device customers worldwide. It offers clinical services that provides development and consulting services to clinical pharmacology and clinical development spectrum. The company also offers delivery models that include full service, functional service provider, and hybrid service structures. In addition, it delivers phase I " IV clinical trial management, clinical pharmacology, and consulting services. Fortrea Holdings Inc. enters into a strategic collaboration with Emery Pharma to provide rapid lot-by-lot, 1-methyl-4-nitrosopiperazine (MNP) testing of rifampin, the preferred drug for drug-drug interaction studies, to certify impurities are below the Acceptable Intake Limit set by U.S. Food and Drug Administration guidelines. The company has a strategic collaboration with SCT Cell Manufacturing s.r.o. to streamline development, accelerate timelines and bring advanced therapies to patients faster. Fortrea Holdings Inc. was incorporated in 2023 and is headquartered in Durham, North Carolina.
Stock Price
$0.00
decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AFortrea Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Fortrea Holdings, Inc. - FTRE Barchart.com
Read more →A Look At Fortrea Holdings (FTRE) Valuation After Recent Analyst Upgrades And Improved Execution Yahoo Finance New Zealand
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
HOLD
Target Price:
$13.2546
Analyst Picks
Strong Buy
0
Buy
1
Hold
10
Sell
1
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very High
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Free Cash Flow - Revenue % (FCF)
-
High
Low ≤ 5%
High ≥ 15%
Debt to Equity
-
Very Low
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Fortrea Holdings Inc.
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
0.12
EPS Estimate
0.48
EPS Difference
-0.36
Surprise Percent
-75%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.